Director/PDMR Shareholding

RNS Number : 9687T

IP Group PLC

01 April 2016

 

FOR RELEASE ON

01 April 2016

IP Group plc - Director / PDMR Shareholding and Issue of Equity

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, announces that it has today issued 457,877 new ordinary shares of 2p each (the "Shares") following the vesting of conditional awards of shares made under the Company's Long-Term Incentive Scheme (the "Scheme") in 2013 (the "2013 Awards").

As a result, the Company today received notification from the following Directors/Persons Discharging Managerial Responsibilities in relation to the acquisition of Shares under the Scheme and subsequent sale, at an aggregate price of 170 pence per share, as set out in the table below. The shares are subject to a further one year post-vesting holding period and thus the shares sold, as detailed below, were done so only to meet income tax and national insurance liabilities.

				Resultant beneficial interest
Director/PDMR	Position	Shares vested	Shares sold	Shares	%
Alan Aubrey	Chief Executive Officer	81,217	44,565	2,490,651	0.44
Mike Townend	Chief Investment Officer	64,974	35,653	1,074,504	0.20
Greg Smith	Chief Financial Officer	45,999	25,243	260,989	0.05
Angela Leach	Company Secretary	55,447	30,426	248,939	0.04

In addition, the Company received notification that Greg Smith has today transferred 24,642 IP Group plc shares into a self-invested personal pension in his own name. His beneficial interest in the Group remains unchanged from that set out above as a result of the transfer.

An application has been made to the Financial Conduct Authority for admission of the Shares to the premium listing segment of the Official List maintained by the UK Listing Authority and to the London Stock Exchange. It is expected that admission will take place on 6 April 2016.

Following this issue of shares, the Company has 565,106,045 ordinary shares in issue.

Awards under Deferred Share Bonus Plan ("DBSP")

On 31 March 2016, awards over IP Group plc shares were made to certain Executive Directors, other persons discharging managerial responsibilities and certain other employees under the Company's DBSP. The awards reflect the deferral of fifty per cent. of each person's award under the Group's Annual Incentive Scheme ("AIS") in respect of the Company's performance for the financial year ended 31 December 2015. The following table sets out details of the awards made to the Executive Directors and PDMRs: 

Name of Director/PDMR	Structure of award	Number of Shares awarded under the DBSP	Total number of Shares held under the DBSP
Alan Aubrey	Nil-Cost Option	85,420	118,457
David Baynes	Nil-Cost Option	51,962	51,962
Mike Townend	Nil-Cost Option	51,962	73,986
Greg Smith	Nil-Cost Option	45,274	60,867
Angela Leach	Nil-Cost Option	39,294	54,887

In addition to the above, awards over a total of 507,236 shares were made to certain other of the Group's employees.

As described above, the awards have been made as a result of the deferral of amounts awarded under the Group's AIS, as will be more fully described in the Group's 2015 Directors' Remuneration Report. The awards have been made pursuant to the rules of the current DBSP.

No consideration was paid for the grant of the awards and no consideration is due on the maturity of the awards. Fifty per cent. of the awards will normally be exercisable on the first anniversary of the date of grant and fifty per cent. on the second anniversary of the date of grant, each generally subject to continued employment. The awards shall be exercisable for a maximum of three years from the date of grant.

The Company was informed of the above transactions on 1 April 2016.

For more information, please contact:

IP Group plc	www.ipgroupplc.com
Alan Aubrey, Chief Executive Officer Greg Smith, Chief Financial Officer Liz Vaughan-Adams, Communications	[phone] [phone]/[phone]
Charlotte Street Partners
Andrew Wilson Chris Sibbald	[phone] [phone]

Notes for editors

About IP Group

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiary IP Capital), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in approximately 100 early-stage to mature businesses across four main sectors -- Biotech, Cleantech, Healthcare and Technology. The Company is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS

 

END

 

 

RDSUGUUACUPQGAG